The Harvard Dermatopathology Fellowship is an ACGME-accredited training program that draws on the facilities of Beth Israel Deaconess Medical Center (BIDMC), Brigham and Women's Hospital (BWH), and Massachusetts General Hospital (MGH). The Harvard Fellowship is based at BWH (Dr. Murphy, Program Director), with Institutional Directors at BIDMC and MGH.
The period of fellowship is one year. Fellows enter the program eligible for Board certification in dermatology or pathology and receive training in the complementary fields of anatomic pathology or clinical dermatology, respectively. Additionally, fellows receive training in dermatoimmunopathology, immunofluorescence, microbiology/mycology, tissue processing for both routine and specialized microscopy, diagnostic electron microscopy, immunohistochemistry, molecular genomics, and laboratory management. The program is unique in requiring rotational exposure to all three of the major Harvard teaching hospitals, exposing fellows with a wide range of faculty expertise and institutional resources.
Clinical and translational research opportunities are available throughout the program, and at least one research project is required. Fellows have abundant opportunities to attend a wide variety of clinical and pathological-diagnostic conferences, and are required to teach in training programs offered to residents and medical students.
The Brigham and Women's Program in Dermatopathology is a component of the Harvard Dermatopathology Program that consists of closely integrated diagnostic, educational, and research units. The Diagnostic Service analyzes daily a large number of diverse and complex specimens derived from the Brigham and Women's clinical practices as well as the Dana Farber Cancer Institute. The Service is supported by comprehensive special diagnostic laboratories that provide a vast array of immunohistochemical and molecular probes.
The Research Division occupies a complementary facility conducting NIH-funded investigation focused on molecular and cellular pathways responsible for cutaneous cytotoxicity, melanocyte/melanoma stem cell biology, skin cancer and transplantation immunology, epigenetics, and proteasome/ubiquitin biology. Thus there exist ample resources for participation in translational research that complements acquisition of basic diagnostic skills requisite for dermatopathology practice and/or for academic careers as clinical educators and physician/scientists.
BWH faculty mentors are actively involved in didactic initiatives, including authorship participation in a number of dermatopathology texts, including recent editions of Pathology of the Skin (Granter), and Lever's Histology of the Skin and the AFIP Fascicles on Melanocytic Tumors of the Skin and Inflammatory Disorders of the Skin (Murphy).
Fellowship candidates must be graduates of approved medical schools in the United States or Canada. Graduates of foreign medical schools must have an ECFMG Certificate. Applicants must have completed a residency training program in either Pathology or Dermatology and be eligible for certification in either one to enter the program. Completed application deadline for 2020 Fellowship is August 15, 2018, and will have an interview date scheduled for mid-September.
Dermatopathology Fellowship application form and inquiries should be submitted to:
Harvard Dermatopathology Fellowship Program
Program in Dermatopathology, Brigham and Women's Hospital
401 Eugene Braunwald Research Center
221 Longwood Avenue
Boston, MA 02115
For over a century, a leader in patient care, medical education and research, with expertise in virtually every specialty of medicine and surgery.